Homologous recombination repair gene-based risk model predicts prognosis and immune microenvironment for primary lung cancer after previous malignancies.

Wang, Haoran; Gong, Fangxiao; Kong, Weicheng; Chen, Yanyan; Zhang, Jie

Wang, Haoran; Gong, Fangxiao; Kong, Weicheng; Chen, Yanyan; Zhang, Jie.

Affiliation

Wang H; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
Gong F; Emergency and Critical Care Center, Intensive Care Unit, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Kong W; Department of Thoracic Surgery, Putuo District People's Hospital, Zhoushan, China.
Chen Y; Division of Pulmonary, SinoUnited Health, Shanghai, China.
Zhang J; Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.

J Gene Med ; 25(11): e3533, 2023 Nov.

Article in En | MEDLINE | ID: mdl-37243581

Subject(s)

Lung Neoplasms; Recombinational DNA Repair; Humans; Recombinational DNA Repair/genetics; Lung Neoplasms/genetics; Serpin E2; Cell Cycle; Immunotherapy; Tumor Microenvironment/genetics

Key words

HRR; PLC after previous malignancies; microenvironment; prognosis; risk model

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinational DNA Repair / Lung Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Gene Med Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google